Headquarters
Menlo Park, CA
Industry
Life Sciences – Medical Device – Ear Nose & Throat
Overview
Acclarent's focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplasty™ devices. Through the Balloon Sinuplasty™ technology and our Relieva® product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches
Solution
QAD ERP was implemented as a robust enterprise platform for expansion and growth.
Results
Acclarent was acquired by Ethicon, Inc., a Johnson & Johnson company for approximately
$785 million in 2010.
